Obstructive sleep apnoea and cardiac disease among Aboriginal patients in the Northern Territory of Australia
SS Heraganahally, B Rajaratnam, SAAS Silva… - Heart, Lung and …, 2021 - Elsevier
Background There is paucity of information on obstructive sleep apnoea (OSA) and cardiac
diseases among Aboriginal Australian patients. This study evaluates the association of …
diseases among Aboriginal Australian patients. This study evaluates the association of …
The challenge of an expanded therapeutic window in pulmonary hypertension
S Stewart, GA Strange, D Playford - Nature Reviews Cardiology, 2020 - nature.com
Our understanding of the causes and consequences of pulmonary hypertension is limited.
Consequently, its most distinctive forms with the worst prognosis have been the focus for …
Consequently, its most distinctive forms with the worst prognosis have been the focus for …
Pulmonary arterial hypertension: updates and perspective with newer therapies
JD Prasad, TJ Williams… - Internal medicine journal, 2024 - Wiley Online Library
Pulmonary arterial hypertension (PAH) is a rare condition for which a remarkable change
has been witnessed in the epidemiology, assessment and treatment landscape over the last …
has been witnessed in the epidemiology, assessment and treatment landscape over the last …
Pulmonary hypertension in remote and disadvantaged population: overcoming unique challenges for improved outcomes
Pulmonary hypertension (PH) is a common and debilitating medical condition with high
mortality. PH research has traditionally focused on pulmonary arterial hypertension and its …
mortality. PH research has traditionally focused on pulmonary arterial hypertension and its …
Top end pulmonary hypertension study: understanding epidemiology, therapeutic gaps and prognosis in remote Australian setting
Introduction The Top End of Australia has a high proportion of Indigenous people with a high
burden of chronic cardiac and pulmonary diseases likely to contribute to pulmonary …
burden of chronic cardiac and pulmonary diseases likely to contribute to pulmonary …
Global Burden of Pulmonary Arterial Hypertension, 1990-2021: A Comprehensive Analysis from the Global Burden of Disease Study 2021
Y Chen, Y Zheng, S Chen, C Li, R Zhang… - Available at SSRN … - papers.ssrn.com
Background: Pulmonary Arterial Hypertension (PAH) poses a significant challenge to global
health. However, the true burden caused by PAH on a global scale remains inadequately …
health. However, the true burden caused by PAH on a global scale remains inadequately …